Yifan Pharmaceutical (002019.SZ) stated on the investor interaction platform on August 31st that the company does not produce products for this indication (monkeypox); at the same time, kindly remind investors not to believe rumors, to rationally distinguish various types of information, and to pay attention to investment risks.
亿帆医药(002019.SZ):公司未生产该类适应症(猴痘)的产品
Yifan Pharmaceutical (002019.SZ): The company has not produced products for this indication (monkeypox).
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.